Georgia Tech and Vanderbilt researchers have built the first lung-on-a-chip with a working immune system, a breakthrough with the potential to reshape how we study disease, move beyond animal testing, and administer lifesaving therapies.
Two years into a $49.5 million cancer-mapping project, researchers are opening the door to new kinds of tests that could alert doctors to multiple kinds of cancer when they’re most treatable.